Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site.
D001053:Apolipoproteins / Q000235:genetics*; D001057:Apolipoproteins E; D001120:Arginine; D003543:Cysteamine / Q000627:therapeutic use; D003545:Cysteine; D006720:Homozygote; D006801:Humans; D006952:Hyperlipoproteinemia Type III / Q000188:drug therapy / Q000235:genetics; D007700:Kinetics; D008077:Lipoproteins, LDL / Q000235:genetics*; D011956:Receptors, Cell Surface / Q000378:metabolism; D011973:Receptors, LDL
D001053:Apolipoproteins; D001057:Apolipoproteins E; D008077:Lipoproteins, LDL; D011956:Receptors, Cell Surface; D011973:Receptors, LDL; D003543:Cysteamine; D001120:Arginine; D003545:Cysteine